Clinical Trial Update: Combined Treatment of RFA and Sorafenib on Recurrent HCC [NA]

View source ↗

Summary

Update on a clinical trial evaluating the combination of radiofrequency ablation and sorafenib for recurrent hepatocellular carcinoma. The current status is unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Southwest Hospital, China | Conditions: HCC, Radiofrequency Ablation | NA | Status: UNKNOWN